Comerica Bank Has $25.30 Million Stake in Merit Medical Systems, Inc. $MMSI

Key Points

• Comerica Bank raised its stake in Merit Medical by 28.9% in Q4 to 287,088 shares—worth about $25.30 million and representing roughly 0.48% of the company.
• Merit reported an EPS beat for the quarter ($1.04 vs. $0.96 expected) with revenue of $393.9M (up 10.9% YoY) and set FY2026 guidance of 4.010–4.150 EPS.
• Analysts maintain a consensus of "Moderate Buy" (seven Buys, three Holds) with an average price target of about $99.56, well above the recent trading price near $67.43.

Comerica Bank increased its stake in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI - Free Report) by 28.9% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 287,088 shares of the medical instruments supplier's stock after acquiring an additional 64,413 shares during the period. Comerica Bank owned 0.48% of Merit Medical Systems worth $25,304,000 as of its most recent filing with the SEC.

A number of other hedge funds have also made changes to their positions in the stock. Norden Group LLC increased its holdings in shares of Merit Medical Systems by 5.7% during the 3rd quarter. Norden Group LLC now owns 2,536 shares of the medical instruments supplier's stock valued at $211,000 after acquiring an additional 137 shares during the last quarter. Sowell Financial Services LLC increased its stake in shares of Merit Medical Systems by 4.2% in the third quarter. Sowell Financial Services LLC now owns 4,355 shares of the medical instruments supplier's stock worth $362,000 after purchasing an additional 174 shares during the period. Blue Trust Inc. increased its stake in shares of Merit Medical Systems by 11.0% in the fourth quarter. Blue Trust Inc. now owns 1,853 shares of the medical instruments supplier's stock worth $163,000 after purchasing an additional 184 shares during the period. First Horizon Corp increased its stake in shares of Merit Medical Systems by 19.7% in the fourth quarter. First Horizon Corp now owns 1,117 shares of the medical instruments supplier's stock worth $98,000 after purchasing an additional 184 shares during the period. Finally, CANADA LIFE ASSURANCE Co increased its stake in shares of Merit Medical Systems by 0.4% in the third quarter. CANADA LIFE ASSURANCE Co now owns 50,667 shares of the medical instruments supplier's stock worth $4,095,000 after purchasing an additional 189 shares during the period. Institutional investors and hedge funds own 99.66% of the company's stock.

Wall Street Analyst Weigh In

A number of analysts have issued reports on MMSI shares. Barrington Research lowered their target price on Merit Medical Systems from $109.00 to $107.00 and set an "outperform" rating on the stock in a report on Monday, April 20th. Needham & Company LLC reaffirmed a "buy" rating and issued a $101.00 target price on shares of Merit Medical Systems in a report on Wednesday, April 1st. Piper Sandler lowered their target price on Merit Medical Systems from $106.00 to $96.00 and set an "overweight" rating on the stock in a report on Friday, April 17th. Citigroup reaffirmed an "outperform" rating on shares of Merit Medical Systems in a report on Monday, April 20th. Finally, BTIG Research started coverage on Merit Medical Systems in a report on Friday, February 6th. They issued a "buy" rating and a $107.00 target price on the stock. Seven investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $99.56.

Merit Medical Systems Stock Performance

MMSI opened at $67.43 on Tuesday. The firm has a market capitalization of $4.02 billion, a P/E ratio of 31.81, a price-to-earnings-growth ratio of 1.93 and a beta of 0.64. The stock's 50 day moving average price is $71.61 and its two-hundred day moving average price is $80.05. The company has a quick ratio of 2.95, a current ratio of 4.34 and a debt-to-equity ratio of 0.46. Merit Medical Systems, Inc. has a 12-month low of $66.34 and a 12-month high of $100.19.

Merit Medical Systems (NASDAQ:MMSI - Get Free Report) last released its earnings results on Tuesday, February 24th. The medical instruments supplier reported $1.04 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.96 by $0.08. Merit Medical Systems had a return on equity of 13.82% and a net margin of 8.48%.The firm had revenue of $393.94 million for the quarter, compared to analyst estimates of $390.77 million. During the same quarter last year, the firm posted $0.93 EPS. The company's revenue was up 10.9% on a year-over-year basis. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. On average, equities analysts forecast that Merit Medical Systems, Inc. will post 3.62 earnings per share for the current year.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company's product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.

Want to see what other hedge funds are holding MMSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merit Medical Systems, Inc. (NASDAQ:MMSI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.